Clinical and paraclinical characteristics and factors associated with occult cervical lymph node metastasis in differentiated thyroid cancer cT1N0M0 treated by transoral endoscopic thyroidectomy
Nội dung chính của bài viết
Tóm tắt
This cross-sectional study analyzed 218 patients diagnosed with cT1N0M0 papillary thyroid carcinoma (PTC) who underwent transoral endoscopic thyroidectomy vestibular approach (TOETVA) at Hanoi Medical University Hospital between January 2020 and December 2023. Patients were classified into two groups based on postoperative pathology: those with occult cervical lymph node metastasis (oCLNM+) and those without (oCLNM−). The mean patient age was 35.3 years, and the majority were female (96.8%). Tumors had a mean size of 6.9mm, were primarily located in a single lobe (87.2%), and were multifocal in 13.8% of cases. Occult lymph node metastasis was identified in 41.3% of patients. Statistical analysis revealed that tumor size greater than 5.5mm and multifocality were significant predictors of oCLNM, with odds ratios of 2.4 (p = 0.028) and higher likelihood of nodal involvement. The median number of harvested lymph nodes was 4 (range: 0 – 22), and the median number of metastatic nodes was 0 (range: 0 – 17). These findings suggest that, even in patients with a clinically negative neck (cN0), there remains a considerable risk of occult lymph node metastases, especially in cases with multifocal tumors and primary tumor size exceeding 5.5mm.
Chi tiết bài viết
Từ khóa
TOETVA, Occult cervical lymph node metastasis
Tài liệu tham khảo
2. Hafez LG, Elkomos BE, El-Shafaei MAM, et al. The risk of central nodal metastasis based on prognostic factors of the differentiated thyroid carcinoma: a systematic review and meta-analysis study. Eur Arch Otorhinolaryngol. 2023;280(6):2675-2686. doi:10.1007/s00405-023-07863-8
3. Sun W, Lan X, Zhang H, et al. Risk Factors for Central Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis. PLoS One. 2015;10(10):e0139021. doi:10.1371/journal.pone.0139021
4. Wen X, Jin Q, Cen X, et al. Clinicopathologic predictors of central lymph node metastases in clinical node-negative papillary thyroid microcarcinoma: a systematic review and meta-analysis. World Journal of Surgical Oncology. 2022;20(1):106. doi:10.1186/s12957-022-02573-7
5. Tang L, Qu RW, Park J, et al. Prevalence of Occult Central Lymph Node Metastasis by Tumor Size in Papillary Thyroid Carcinoma: A Systematic Review and Meta-Analysis. Curr Oncol. 2023;30(8):7335-7350. doi:10.3390/curroncol30080532
6. Nguyen HX, Nguyen HX, Nguyen TTP, et al. Transoral endoscopic thyroidectomy by vestibular approach in Viet Nam: surgical outcomes and long-term follow-up. Surg Endosc. 2022;36(6):4248-4254. doi:10.1007/s00464-021-08759-6
7. Xuan HN, Anh TD, Xuan HN, et al. Occult Central Lymph Node Metastasis in cN0 Papillary Thyroid Carcinoma Patients Undergoing TOETVA Procedure. J Thyroid Res. 2023;2023:4779409. doi:10.1155/2023/4779409
8. Nguyen HX, Nguyen HX, Nguyen HV, et al. Transoral Endoscopic Thyroidectomy by Vestibular Approach with Central Lymph Node Dissection for Thyroid Microcarcinoma. Journal of Laparoendoscopic & Advanced Surgical Techniques. 2021;31(4):410-415. doi:10.1089/lap.2020.0411
9. Nguyen Xuan Hau, Nguyen Xuan Hien, Hoang Thi Hoai, et al. Quality of Life and Surgical Outcome of Transoral Endoscopic Thyroidectomy Vestibular Approach (TOETVA) versus Open Thyroid Surgery: Experience from a Single Center in Vietnam. Journal of Thyroid Research. 2022 Oct 11;2022:2381063.
10. Kwon O, Lee S, Bae JS. The role of prophylactic central compartment neck dissection in patients with T1–T2 cN0 papillary thyroid carcinoma. Gland Surg. 2023;12(3):344-353. doi:10.21037/gs-22-550
11. Xiang Y, Lin K, Dong S, et al. Prediction of central lymph node metastasis in 392 patients with cervical lymph node-negative papillary thyroid carcinoma in Eastern China. Oncology Letters. 2015;10(4):2559-2564. doi:10.3892/ol.2015.3544
12. Wu X, Li B, Zheng C, et al. Predicting factors of central lymph node metastases in patients with unilateral multifocal papillary thyroid microcarcinoma. Gland Surgery. 2020;9(3):69501-69701. doi:10.21037/gs.2020.03.27
13. Huang Y, Yin Y, Zhou W. Risk Factors for Central and Lateral Lymph Node Metastases in Patients With Papillary Thyroid Micro-Carcinoma: Retrospective Analysis on 484 Cases. Front Endocrinol (Lausanne). 2021;12:640565. doi:10.3389/fendo.2021.640565
14. Kayhan Y, Azizova L, Yılmaz M, et al. Prognostic factors for aggressiveness in subcentimeter papillary thyroid carcinoma: impact of tumor size and lymph node metastases. Arch Endocrinol Metab. 2024;68:e230422. doi:10.20945/2359-4292-2023-0422
15. Zhang L, Wei W jun, Ji Q hai, et al. Risk Factors for Neck Nodal Metastasis in Papillary Thyroid Microcarcinoma: A Study of 1066 Patients. The Journal of Clinical Endocrinology & Metabolism. 2012;97(4):1250-1257. doi:10.1210/jc.2011-1546
16. Nixon IJ, Kuk D, Wreesmann V, et al. Defining a Valid Age Cutoff in Staging of Well-Differentiated Thyroid Cancer. Ann Surg Oncol. 2016;23(2):410-415. doi:10.1245/s10434-015-4762-2
17. Liang-Sen Liu, Jia Liang, Jun-Hong Li, et al. The incidence and risk factors for central lymph node metastasis in cN0 papillary thyroid microcarcinoma: a meta-analysis. European Archives of Oto-Rhino-Laryngology. 2017;274:1327-1338.
18. Adam MA, Pura J, Goffredo P, et al. Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer. JCO. 2015;33(21):2370-2375. doi:10.1200/JCO.2014.59.8391
19. Lai X, Xia Y, Zhang B, et al. A meta-analysis of Hashimoto’s thyroiditis and papillary thyroid carcinoma risk. Oncotarget. 2017;8(37):62414-62424. doi:10.18632/oncotarget.18620
20. Song E, Jeon MJ, Park S, et al. Influence of coexistent Hashimoto’s thyroiditis on the extent of cervical lymph node dissection and prognosis in papillary thyroid carcinoma. Clin Endocrinol (Oxf). 2018;88(1):123-128. doi:10.1111/cen.13475
21. Yoo HS, Shin MC, Ji YB, et al. Optimal extent of prophylactic central neck dissection for papillary thyroid carcinoma: Comparison of unilateral versus bilateral central neck dissection. Asian J Surg. 2018;41(4):363-369. doi:10.1016/j.asjsur.2017.03.002
22. Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. Thyroid. 2017;27(3):315-389. doi:10.1089/thy.2016.0457
23. Matthew L White, Paul G Gauger, Gerard M Doherty. Central Lymph Node Dissection in Differentiated Thyroid Cancer. World Journal of Surgery. 2007;31:895-904.
24. Liu Z, Li Y, Wang Y, et al. Comparison of the transoral endoscopic thyroidectomy vestibular approach and open thyroidectomy: A propensity score-matched analysis of surgical outcomes and safety in the treatment of papillary thyroid carcinoma. Surgery. 2021;170(6):1680-1686. doi:10.1016/j.surg.2021.06.032